1. Home
  2. KYMR vs HURN Comparison

KYMR vs HURN Comparison

Compare KYMR & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • HURN
  • Stock Information
  • Founded
  • KYMR 2015
  • HURN 2002
  • Country
  • KYMR United States
  • HURN United States
  • Employees
  • KYMR N/A
  • HURN N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • HURN Professional Services
  • Sector
  • KYMR Health Care
  • HURN Consumer Discretionary
  • Exchange
  • KYMR Nasdaq
  • HURN Nasdaq
  • Market Cap
  • KYMR 3.1B
  • HURN 2.6B
  • IPO Year
  • KYMR 2020
  • HURN 2004
  • Fundamental
  • Price
  • KYMR $44.64
  • HURN $132.50
  • Analyst Decision
  • KYMR Strong Buy
  • HURN Strong Buy
  • Analyst Count
  • KYMR 16
  • HURN 4
  • Target Price
  • KYMR $58.94
  • HURN $170.75
  • AVG Volume (30 Days)
  • KYMR 865.2K
  • HURN 174.2K
  • Earning Date
  • KYMR 08-06-2025
  • HURN 07-29-2025
  • Dividend Yield
  • KYMR N/A
  • HURN N/A
  • EPS Growth
  • KYMR N/A
  • HURN 92.74
  • EPS
  • KYMR N/A
  • HURN 6.67
  • Revenue
  • KYMR $58,885,000.00
  • HURN $1,525,814,000.00
  • Revenue This Year
  • KYMR $58.26
  • HURN $11.50
  • Revenue Next Year
  • KYMR N/A
  • HURN $7.48
  • P/E Ratio
  • KYMR N/A
  • HURN $19.88
  • Revenue Growth
  • KYMR N/A
  • HURN 8.98
  • 52 Week Low
  • KYMR $19.45
  • HURN $97.40
  • 52 Week High
  • KYMR $53.27
  • HURN $155.00
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 55.84
  • HURN 38.60
  • Support Level
  • KYMR $43.56
  • HURN $134.78
  • Resistance Level
  • KYMR $46.34
  • HURN $140.24
  • Average True Range (ATR)
  • KYMR 1.81
  • HURN 3.21
  • MACD
  • KYMR -0.60
  • HURN 0.17
  • Stochastic Oscillator
  • KYMR 36.21
  • HURN 17.71

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

Share on Social Networks: